Artículos por temáticas

Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation

Hooper C, Coley N, De Souto Barreto P, Payoux P, Salabert AS, Andrieu S, Weiner M, Vellas B.

J Prev Alzheimers Dis. 2020;7(2):128-134. doi: 10.14283/jpad.2020.4.

Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?

Saponaro F, Kim JH, Chiellini G.

Int J Mol Sci. 2020 Nov 17;21(22):8672. doi: 10.3390/ijms21228672.

Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

Plotkin SS, Cashman NR.

Neurobiol Dis. 2020 Oct;144:105010. doi: 10.1016/j.nbd.2020.105010. Epub 2020 Jul 16.

Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease

Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K.

Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease

Liu CS, Herrmann N, Gallagher D, Rajji TK, Kiss A, Vieira D, Lanctôt KL.

J ECT. 2020 Sep;36(3):211-215. doi: 10.1097/YCT.0000000000000639.

Synthesis, characterization, and biological studies of chalcone derivatives containing Schiff bases: Synthetic derivatives for the treatment of epilepsy and Alzheimer's disease

Koçyiğit ÜM, Gezegen H, Taslimi P.

Arch Pharm (Weinheim). 2020 Dec;353(12):e2000202. doi: 10.1002/ardp.202000202. Epub 2020 Aug 20.

PPARα serves as a new receptor of aspirin for neuroprotection

Patel D, Roy A, Pahan K.

J Neurosci Res. 2020 Apr;98(4):626-631. doi: 10.1002/jnr.24561. Epub 2019 Dec 3.

Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease

Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.

Int J Mol Sci. 2020 Mar 14;21(6):1992. doi: 10.3390/ijms21061992.

Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease

de Freitas GB, Lourenco MV, De Felice FG.

J Neurochem. 2020 Dec;155(6):602-611. doi: 10.1111/jnc.15039. Epub 2020 Jun 2.

[Molecular Basis of Preventive Effects of Habitual Coffee Intake against Chronic Diseases]

Tamura H.

Yakugaku Zasshi. 2020;140(11):1351-1363. doi: 10.1248/yakushi.20-00150.

Anti-Amyloid Aggregating Gold Nanoparticles: Can they Really be Translated from Bench to Bedside for Alzheimer's Disease Treatment?

Shaikh S, Nazam N, Danish Rizvi SM, Hussain T, Farhana A, Choi I.

Curr Protein Pept Sci. 2020;21(12):1184-1192. doi: 10.2174/1389203721666200226101930.

Pisa syndrome induced by switching of a choline-esterase inhibitor treatment from donepezil to galantamine: a case report

Mimura Y, Kurose S, Takata T, Tabuchi H, Mimura M, Funayama M.

BMC Neurol. 2020 May 13;20(1):183. doi: 10.1186/s12883-020-01769-2.

Extrapyramidal side effect of donepezil hydrochloride in an elderly patient: A case report

Li HC, Luo KX, Wang JS, Wang QX.

Medicine (Baltimore). 2020 Mar;99(11):e19443. doi: 10.1097/MD.0000000000019443.

Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery

Bahadur S, Sachan N, Harwansh RK, Deshmukh R.

Curr Pharm Des. 2020;26(12):1331-1344. doi: 10.2174/1381612826666200311131658.

O-GlcNAcylation as a Therapeutic Target for Alzheimer's Disease

Park J, Lai MKP, Arumugam TV, Jo DG.

Neuromolecular Med. 2020 Jun;22(2):171-193. doi: 10.1007/s12017-019-08584-0. Epub 2020 Jan 1.